- AU$2.00bn
- AU$2.26bn
- AU$340.06m
- 62
- 41
- 39
- 46
Annual income statement for PEXA, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | C2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 156 | 221 | 280 | 282 | 340 |
| Cost of Revenue | |||||
| Gross Profit | 133 | 192 | 245 | 247 | 290 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 166 | 193 | 241 | 280 | 346 |
| Operating Profit | -10.7 | 28.4 | 38.7 | 1.73 | -6.09 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.77 | -8.09 | 32.9 | -3.16 | -8.78 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.03 | -11.8 | 21.9 | -21.8 | -18 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.03 | -11.8 | 21.9 | -21.8 | -18 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.03 | -11.8 | 21.9 | -21.8 | -18 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.021 | -0.016 | 0.213 | -0.118 | -0.061 |
| Dividends per Share |